INTRODUCTION
. 5 In addition, inhibitory KIR/HLA interactions are required for NK cells to mature and gain functional competence to be triggered through their activation receptors, a process referred to as licensing or education. 5 Both KIR and HLA loci show extreme population diversity and rapid evolution, suggesting that they are under pathogen-mediated selection and that they influence disease outcome at the individual level. 6 Indeed, several epidemiological studies have associated KIR/HLA compound genotypes with susceptibility to infectious diseases, autoimmune and inflammatory conditions, and cancer. 7 KIR/HLA polymorphisms were also found to act under inter-individual or allogeneic conditions, e.g. by influencing reproductive success and transplantation outcome.
Notably, in the setting of hematopoietic stem cell transplantation as a treatment for acute myeloid leukemia, allogeneic donor/recipient KIR/HLA combinations were associated with leukemia eradication, protection from graft versus host disease, and lower relapse rates. [8] [9] [10] [11] Beneficial KIR/HLA combinations specifically consisted of donor inhibitory KIR that recognized HLA allotypes present in the donor but that were lacking in the recipient. Functional studies showed that such 'missing self' combinations correlated with the expansion of a donorderived alloreactive NK cell subset in the recipient with strong alloreactivity towards residual immune and leukemia cells in a donor-to-recipient direction. 8, 10 Similar allogeneic KIR/HLA ligand mismatches but in the recipient-to-donor direction were found associated with reduced graft survival after HLA-C incompatible kidney transplantation. 12 HIV-1 acquisition and transmission efficiency is highly variable between individuals and depends on host, viral as well as environmental factors. 13 Host genetics can have an important impact on HIV-1 acquisition, with polymorphisms in CCR5 and HLA as most replicated examples. 14 Notably, the level of HLA class I allele discordance between transmission pairs correlates with a decreased risk of sexual or perinatal HIV-1 transmission. [15] [16] [17] [18] [19] KIR/HLA combinations influence the rate of HIV-1 disease progression. [20] [21] [22] [23] [24] [25] [26] [27] Studies of HIV-exposed seronegative (HESN) individuals also showed an effect of KIR/HLA genetic variation on susceptibility to HIV-1 acquisition, [28] [29] [30] [31] [32] [33] [34] with several of those reporting KIR/HLA combinations with an NK cell activating profile to be characteristic of HESN subjects. [28] [29] [30] 32 To date, no study has investigated the impact of allogeneic KIR/HLA combinations across sexual partners on HIV-1 transmission.
In this study, we investigated whether specific allogeneic KIR/HLA combinations, like those applied in hematopoietic stem cell transplantation, influence HIV-1 transmission and lack thereof in a West African population of HIV-1-discordant (one partner HIV-1-positive, other partner HIV-1-negative) and HIV-1-concordant (both partners HIV-1-positive) couples. In agreement with our previous study of HESN female sex workers, 28 we found that HIV-1 transmission in heterosexual couples depends on the KIR/HLA genotype of the recipient partners. In addition,
HIV-1 transmission and lack thereof correlated with the presence of specific matched and mismatched allogeneic KIR/HLA combinations across partners which we found were predictive of NK cell-mediated killing of allogeneic target cells.
METHODS

Study populations
HIV-1-discordant, HIV-1-concordant, and HIV-negative couples were recruited at the outpatient clinic of Fann Hospital in Dakar, Senegal. Blood samples and standard questionnaires with information on sociodemographics and sexual behavior were collected. Index and recipient partners in HIV-1-discordant couples were the HIV-1-infected and uninfected partners, respectively, with all uninfected partners considered as HESN. All HIV-1-concordant couples included in this study showed confirmed phylogenetic linkage of transmitted viruses and directionality of intracouple transmission, 35 and index and recipient partners were assigned accordingly. Committees of the Senegalese Ministry of Health and the University Hospital of Antwerp. All study subjects gave written informed consent prior to enrollment.
Sample collection and HIV testing
Whole blood was drawn into EDTA tubes (Becton Dickinson). Plasma and peripheral blood mononuclear cells (PBMC) were separated from whole blood by density gradient centrifugation.
Plasma and dry PBMC pellets were stored at -80°C. HIV status was evaluated in plasma by current serological testing combining ELISAs and Western blots. The HIV-negative status of HESN partners in HIV-1-discordant couples was confirmed by HIV-1 and HIV-2 diagnostic PCR on genomic DNA extracted from PBMC.
KIR and HLA genotyping
Genomic DNA was extracted from peripheral blood mononuclear cells using a QIAamp DNA blood mini kit (Qiagen and/or KIR2DS1, and telomeric BB genotypes lack KIR3DL1 and/or KIR2DS4. HLA-B and HLA-C typing was performed by PCR with sequence specific oligonucleotides using LABType SSO genotyping kits (One Lambda). The 2-digit typing results permit to distinguish Bw4-80I and Bw4-80T alleles from Bw6 alleles, and C1 alleles from C2 alleles.
NK cell killing assay
PBMC were separated from fresh whole blood and buffycoat samples obtained from HIV-1 patients and healthy blood donors, respectively. NK cells were magnetically purified from blood donor PBMC by negative selection according to the manufacturer's instructions (Miltenyi Biotec), and incubated at 37°C and 5% CO 2 during two days in R10 (RPMI containing 100 U/ml of penicillin, 100 µg/ml of streptomycin, and 10% FBS) supplemented with 200 units/ml IL-2 
RESULTS
Characteristics of the study population
Thirty-five HIV-1-discordant, 35 HIV-1-concordant, and 38 HIV-negative couples were included in the study. Demographic, clinical and behavioral characteristics of the couples are summarized in Table 1 . The different couple groups showed comparable age distributions, they were all predominantly of Senegalese origin, and they reported comparable relationship durations and sexual contact frequencies. HIV-1-discordant couples reported more frequent condom use than HIV-negative and HIV-1-concordant couples. Index partners in HIV-1-concordant couples were more frequently the male partner compared to those in HIV-1-discordant couples.
HESN subjects show a higher frequency of KIR2DL2 and a lower frequency of KIR2DL3 than HIV-1-infected controls
Previous studies observed specific KIR profiles in HESN subjects. 28, 30, 32 To confirm these findings, we compared frequencies of KIR genes and KIR genotypes between HESN partners (HIV uninfected partners in HIV-1-discordant couples), HIV-1-infected controls (both partners of HIV-1-concordant couples), and low risk controls (both partners of HIV-negative couples).
HESN subjects displayed significantly higher frequencies of KIR2DL2 and KIR2DS2 and a significantly lower frequency of KIR2DL3 than HIV-1-infected controls ( Figure 1A -B).
KIR2DL2 and KIR2DL3, alleles of the same gene locus, are characteristic of centromeric group B and group A haplotypes, respectively. 36,37 HESN subjects were more frequently KIR2DL2
homozygous and less frequently KIR2DL3 homozygous than HIV-1-infected controls, consistent HESN subjects show a higher frequency of KIR2DL2 in the absence of HLA-C1 than
HIV-1-infected controls
KIR2DL2 and KIR2DL3 regulate NK cell function in an HLA-C dependent manner. Therefore, we investigated whether the observed differences in KIR2DL2/KIR2DL3 frequencies between the subject groups were influenced by concurrent carriage of cognate HLA-C alleles, first within the same individuals. On their own, there were no differences in C1 or C2 allele frequencies between the 3 subject groups (data not shown). The higher frequency of homozygous KIR2DL3
among HIV-1-infected controls did not preferably occur together with C1 or C2 (data not shown). The higher frequency of homozygous KIR2DL2 among HESN subjects, however, appeared statistically significant only in the absence of C1 (i.e. together with homozygous C2;
9% of HESN vs. 0% of HIV-1-infected controls, P = 0.037). We found no differences in the frequencies of Bw4-80I or Bw4-80T, alone or in combination with KIR3DS1 or KIR3DL1, between the 3 groups (data not shown). 11 To test this, we compared frequencies of 'missing self' and 'matched' KIR/HLA combinations between partners of HIV-1-discordant and concordant couples included in our study ( Table 2) . We found that HIV-1-discordant couples were characterized by a recipient partner KIR2DL1/HLA-C2 with index partner HLA-C1/C1 combination (OR = 10.1, P = 0.028), allowing licensed 'missing self' NK cell killing of index cells through KIR2DL1. HIV-1-concordant couples on the other hand were characterized by KIR2DL3 homozygous recipient partners with HLA-C1/C2 bearing index partners (OR = 0.06, P = 0.001), resulting in a matched KIR/HLA combination expected to inhibit NK cell killing through KIR2DL3 (and KIR2DL1 which is present in most subjects of our study population).
The higher frequency of homozygous KIR2DL2 among HESN recipient partners in HIV-1-discordant couples did not significantly correlate with a specific index partner HLA-C genotype.
We found no differences in allogeneic combinations of KIR3DS1 or KIR3DL1 with HLA-Bw4 between HIV-1-discordant and concordant couples (data not shown).
Allogeneic KIR/HLA combinations independently predict couple status
Next, we investigated whether the identified KIR/HLA combinations correlated independently with the HIV-1-discordant or concordant status of the couples by use of stepwise multivariate logistic regression (Table 3 ). All models were controlled for index partner sex, which was significantly different between HIV-1-discordant and concordant couples. The 'missing self' KIR2DL1/HLA-C2 with HLA-C1/C1 combination and the 'matched' homozygous KIR2DL3
with HLA-C1/C2 combination independently predicted couple status and together they made up the best model (Table 3 , model 3). Recipient homozygous KIR2DL3 and to a large extent also recipient homozygous KIR2DL2 did not independently contribute to the couple status ( (Table 4) . Of the 12 donor/patient pairs tested, 7 were characterized by a licensed 'missing self' KIR/HLA combination (1 of which had the exact donor KIR2DL1/HLA-C2 with patient HLA-C1/C1 combination characteristic of HIV-1-discordant couples) and these showed the highest levels of CD4+ T cell killing (Table 4 and Figure 2 ). Five donor/patient pairs lacked a 'missing self' KIR/HLA combination (3 of which had the homozygous KIR2DL3 with HLA-C1/C2 combination characteristic of HIV-1-concordant couples) and these showed the lowest levels of CD4 killing (Table 4 and Figure 2 ). The KIR3DS1/HLA-Bw4 combination, previously associated with protection against HIV-1 disease progression and in vitro inhibition of viral replication 20,27,40 but tested here in allogeneic constellation, also showed high levels of CD4+ T cell killing (Table 4 and Figure 2 ). Possession of a centromeric KIR BB genotype (i.e.
homozygous KIR2DL2) did not associate with increased levels of NK cell-mediated killing. These data corroborate our previous findings in HESN female sex workers from Côte d'Ivoire who were also characterized by group B KIR haplotypes and specific autologous inhibitory KIR/HLA mismatches. 28 Other studies of European and Asian HESN populations found higher frequencies of KIR3DS1, 30 lower frequencies of KIR3DL1 in the presence of its HLA-Bw4 ligand, 32 and increased KIR3DS1/KIR3DL1 transcript ratios 29 , together supporting the conclusion that KIR/HLA genotypes with an activating profile are protective against HIV-1 acquisition.
HIV-1 transmission occurs at least in part through incoming HIV-1-infected cells (cell-associated
virus) present in genital secretions. 38, 39 We hypothesized that NK cells from the recipient partner capable of directly eliminating incoming HIV-infected cells from the index partner before any viral replication in the recipient can occur could offer strong protection against HIV-1 acquisition.
According to the principles of 'missing self' and NK cell education, 5 functional studies showed increased levels of NK cell activation in HESN subjects, 29, [41] [42] [43] [44] but NK cell alloreactivity has never been shown. In that regard, although we limited IL-2 pre-activation of NK cells to only 2 days to mimic ex vivo conditions, it would also be relevant to investigate whether our findings can be reproduced using freshly isolated resting NK cells.
Our data confirm and extend previous studies of HIV-1-discordant couples and mother-infant pairs showing HLA class I allele discordance between transmission pairs to be associated with a decreased risk of sexual or perinatal HIV-1 transmission. [15] [16] [17] [18] [19] HLA class I discordance was proposed to result in more efficient HLA-restricted CTL targeting of incoming viruses pre-adapted to the index partners' HLA. In addition, alloreactivity was considered as a plausible explanation as well. Indeed, HLA class I discordant transmission pairs are more likely to be also KIR ligand mismatched, implying a role for NK cell alloreactivity in previous transmission studies.
Our findings are in accordance with our current understanding of NK cell alloreactivity, which occurs when NK cells educated by inhibitory KIR recognizing a self HLA respond to allogeneic target cells that are lacking this HLA (missing self). This model emerged from studies of haploidentical hematopoietic stem cell transplantation as a treatment for acute myeloid leukemia. [8] [9] [10] [11] In these studies, allogeneic KIR/HLA mismatches resulted in the expansion of a donor-derived alloreactive NK cell subset in the recipient with strong alloreactivity towards residual immune and leukemia cells leading to leukemia eradication and protection from graft versus host disease. Other studies of hematopoietic stem cell transplantation however observed better prognosis when donors had activating KIR2DS1 and KIR2DS2 or when they carried a centromeric KIR BB genotype. 37, 45 These data are also in agreement with our findings, although in our study the effect of recipient KIR genotype appeared largely secondary to that of recipient/index allogeneic KIR/HLA combinations. Recent data showed the importance of KIR2DS1-positive HLA-C2-negative stem cell donors in leukemia outcome, 46 reflecting the negative effect of self HLA-C2 on the responsiveness of KIR2DS1-positive NK cells. 
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